Abstract: A cell culture comprising human foreskin cells, the human foreskin cells being capable of maintaining stem cells in an undifferentiated state when co-cultured therewith.
Type:
Grant
Filed:
August 19, 2014
Date of Patent:
February 9, 2016
Assignee:
Technion Research & Development Foundation Limited
Abstract: A method of preserving organisms in viable form, the method comprising: suspending organisms in a solution of electrospinnable polymer; drawing droplets of said solution through a spinneret; applying an electrostatic field to said droplets under electrospinning conditions; so as to form fibers having a diameter no greater than about 5 ?m within which distinct organisms are encapsulated in viable form.
Type:
Application
Filed:
August 4, 2015
Publication date:
February 4, 2016
Applicant:
Technion Research & Development Foundation Limited
Abstract: Systems and methods using contrast enhanced ultrasound imaging for quantitative assessment of neovascularization, such as within a tumor or a plaque. The contrast agent moves in small blotches rather than in continuous flow, but image processing methods enable the detection and quantification of the blood flow, even in the tiny blood vessels of the vasculature tree. The image processing includes compensation for motion of the tissue arising from body movement. The position and extent of the discrete positions of contrast material may be accumulating during a complete heart cycle onto a single 2D image, to enable an indication of a vascular tree based on this local accumulated image. Dynamic processing (DP) of the discrete positions of contrast material enables a complete vascular tree to be obtained. The neovascularization is quantified by the ratio of its total area to that of the plaque in which the neovascularization has grown.
Type:
Grant
Filed:
January 30, 2013
Date of Patent:
December 22, 2015
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Assaf Hoogi, Avinoam Bar-Zion, Dan Adam
Abstract: Method comprising: applying uncured pre-gel (UP) to surface; contacting UP with cross-linking agents; allowing applied UP to cure, increasingly adhere to first surface, source of agents: solid support comprising agent, or insoluble agent salt in UP, wherein trigger compound is added to UP, or spraying/coating agent, with solid support added.
Type:
Grant
Filed:
June 1, 2010
Date of Patent:
December 22, 2015
Assignee:
Technion Research & Development Foundation Ltd.
Abstract: Decellularized tissue-derived extracellular matrices (ECM) and methods of generating and using same are provided. The method of generating a decellularized matrix includes the steps of: (a) subjecting the tissue to washes and a hypertonic buffer; (b) subjecting the tissue to an enzymatic proteolytic digestion with an enzyme such as trypsin; and (c) removing all cellular components from the tissue using a detergent solution which includes Triton-X-100 and ammonium hydroxide. Specifically, there is provided a decellularized myocardium-derived matrix which is completely devoid of all cellular components and hence non-immunogenic in a subject, exhibits suitable structural and mechanical properties for cardiac tissue engineering or replacement therapy of damaged cardiac tissue, and is capable of remodeling upon seeding of cells.
Type:
Grant
Filed:
March 7, 2006
Date of Patent:
December 22, 2015
Assignee:
Technion Research & Development Foundation Limited
Abstract: A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
Type:
Application
Filed:
June 14, 2015
Publication date:
December 10, 2015
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Timor BAASOV, Tamar Ben-Yosef, Igor Nudelman, Annie Rebibo-Sabbah, Dalia Shallom-Shezifi, Mariana Hainrichson
Abstract: An isolated primate embryonic cell is provided as well as cell cultures and cell lines derived therefrom. Also provided are methods of generating and using such cells.
Type:
Grant
Filed:
December 27, 2012
Date of Patent:
December 8, 2015
Assignee:
Technion Research & Development Foundation Limited
Abstract: A resonator system for electron spin resonance (ESR) is disclosed. The resonator system comprises: a generally planar resonator layer defining an open-loop gapped by a non-conductive gap in the layer, and a microwave feed, positioned configured for transmitting microwave to the resonator layer such as to concentrate, with a quality factor of at least 100, a magnetic field within an effective volume of less than 1 nL above the layer.
Type:
Grant
Filed:
October 18, 2011
Date of Patent:
November 24, 2015
Assignee:
Technion Research & Development Foundation Limited
Abstract: A new class of pseudo-trisaccharide aminoglycosides having an alkyl group at the 5? position, exhibiting efficient stop codon mutation readthrough activity, low cytotoxicity and high selectivity towards eukaryotic translation systems are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders, as well as processes of preparing these aminoglycosides. The disclosed aminoglycosides can be represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification.
Type:
Grant
Filed:
August 18, 2014
Date of Patent:
November 3, 2015
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Timor Baasov, Dana Atia-Glikin, Jeyakumar Kandasamy, Valery Belakhov
Abstract: Silicon-oxygen batteries comprising a silicon anode as chemical fuel, an air-cathode for dissociating oxygen and a non-aqueous electrolyte, and applications using the same are provided. The silicon-batteries may utilize air for generating oxygen.
Type:
Grant
Filed:
February 11, 2010
Date of Patent:
October 13, 2015
Assignees:
Technion Research & Development Foundation Limited, The Penn State Research Foundation
Abstract: A computerized method of creating a presentation of multidimensional objects in a multidimensional presentation space. The method comprises providing a core element which applies any of functions on a multidimensional object in a multidimensional presentation space, providing a plurality of adaptation components each contains instructions for converting any media object of another of different media types each to a multidimensional object in the multidimensional presentation space, receiving a media object, identifying a matching adaptation component from the adaptation components according to a respective media type of the media object, converting the media objects into a multidimensional object in the multidimensional presentation space using the matching adaptation component, and applying any of the functions on the multidimensional object, using the core element, according to a user selection.
Type:
Grant
Filed:
October 23, 2012
Date of Patent:
October 13, 2015
Assignee:
Technion Research & Development Foundation Limited
Abstract: Provided herein are antimicrobial conjugates of two antibiotic agents, exhibiting improved activity also against resistant bacteria, compared to each of the agents separately or their mixture, and having substantially no resistance emerged thereagainst, as well as processes for preparation the same, compositions containing the same, and uses thereof in medical treatments against pathogenic microorganisms. The disclosed antimicrobial conjugates are composed of aminoglycosides and non-ribosomal active antibiotics. Some of the antimicrobial conjugates are prepared via “click” chemistry.
Type:
Grant
Filed:
August 18, 2014
Date of Patent:
October 6, 2015
Assignee:
Technion Research & Development Foundation Limited
Abstract: Provided are methods of isolating an extracellular matrix from mesenchymal progenitor cells which are characterized by a reduced differentiation ability into an adipogenic lineage as compared to adipose-derived mesenchymal stem cells. Also provide isolated extracellular matrix and hybrid devices comprising electrospun elements and extracellular matrix which can be used for various tissue regeneration, repair and reconstruction surgeries.
Type:
Grant
Filed:
July 27, 2011
Date of Patent:
September 29, 2015
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Joseph Itskovitz-Eldor, Ronit Shtrichman, Eyal Zussman, Efrat Barak
Abstract: A novel process of preparing a Grignard reagent is disclosed. The process is effected by electrochemically reacting a Grignard precursor with an electrode which comprises a metal for forming the Grignard reagent, in the presence an electrolyte solution that comprises a room temperature ionic liquid (RTIL). Electrochemical cells and systems for performing the process, and uses thereof in various applications are also disclosed.
Type:
Grant
Filed:
November 19, 2013
Date of Patent:
September 29, 2015
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Yair Ein-Eli, Daniel Luder, Alexander Kraytsberg
Abstract: A microparticle for cell encapsulation is provided, having a core which comprises continuous fibers of decellularized extracellular matrix (ECM).
Type:
Application
Filed:
September 3, 2013
Publication date:
August 6, 2015
Applicant:
Technion Research & Development Foundation Limited
Abstract: A method of preserving organisms in viable form, the method comprising: suspending organisms in a solution of electrospinnable polymer; drawing droplets of said solution through a spinneret; applying an electrostatic field to said droplets under electrospinning conditions; so as to form fibers having a diameter no greater than about 5 ?m within which distinct organisms are encapsulated in viable form.
Type:
Grant
Filed:
August 29, 2007
Date of Patent:
August 4, 2015
Assignee:
Technion Research & Development Foundation Limited
Abstract: A composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region capable of specifically binding an antigen-presenting portion of a complex composed of a human antigen-presenting molecule and an antigen derived from a pathogen is disclosed.
Type:
Grant
Filed:
November 19, 2009
Date of Patent:
August 4, 2015
Assignee:
Technion Research & Development Foundation Limited
Abstract: A method of applying a nondestructive mechanical force on one or more cells in aqueous environment by inducing heat generated acoustic pressure pulses. The method comprises providing an energy transmission pattern to induce the applying of a desired nondestructive mechanical force on a at least one cell by forming a plurality of heat generated acoustic pressure pulses in an aqueous environment and instructing the radiation of a target area in proximity to the at least one cell in the aqueous environment with light energy according to the energy transmission pattern.
Type:
Grant
Filed:
November 8, 2012
Date of Patent:
August 4, 2015
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Eitan Kimmel, Shy Shoham, Boris Krasovitski
Abstract: An isolated homogeneous population of cells comprising a plurality of human ectodermal progenitor cells. Also provided are methods of generating and using the population of cells.
Type:
Grant
Filed:
March 27, 2008
Date of Patent:
July 21, 2015
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Daniel Aberdam, Edith Aberdam, Efrat Barak, Michal Amit, Joseph Itskovitz-Eldor
Abstract: A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
Type:
Grant
Filed:
October 1, 2008
Date of Patent:
July 7, 2015
Assignee:
Technion Research & Development Foundation Limited
Inventors:
Timor Baasov, Tamar Ben-Yosef, Igor Nudelman, Annie Rebibo-Sabbah, Dalia Shallom-Shezifi, Mariana Hainrichson